# Post-Test Decision Recommendation

## Recommended action
**DO NOT roll out this week. Extend observation to determine whether the effect stabilizes before committing to full rollout.**

## Why this action is appropriate

The experiment shows a statistically significant result (p=0.004) and achieves the Q3 OKR target at face value (+2.9pp toward the 3% DAU improvement goal). However, the week-by-week breakdown reveals a critical concern that dominates the decision: **this is a novelty effect, not a sustained improvement**.

The decay pattern is stark:
- Week 1: +7.8 percentage points (control: 41.2% → test: 49.0%)
- Week 2: +2.1 percentage points (narrowing to 43.3%)
- Week 3: +0.8 percentage points (further decay to 42.0%)

The aggregate +2.9pp result is heavily weighted toward the Week 1 spike. If this decay continues, the steady-state effect may stabilize near the Week 3 level (±0.8pp) or potentially approach zero. This would mean the algorithm is delivering a novelty boost that users habituate to, not a sustained improvement in engagement.

## Risks of rolling out now

1. **Overstating the true effect**: The aggregate result obscures that 66% of the observed lift came from Week 1 alone. Long-term impact may be far smaller than the +2.9pp headline.
2. **Sunk cost bias**: Shipping this week to "count toward Q3" is deadline pressure, not evidence. If the effect decays further, you'll have implemented medium-complexity infrastructure for an unsustainable uplift.
3. **Future disappointment**: If steady-state performance is 0.8pp or lower, the Q3 gain is illusory—the metric will decline toward baseline in subsequent weeks.
4. **Guardrail confidence is limited**: Session depth and shares are stable, which is good, but these don't guarantee user satisfaction with a novelty feature that loses appeal.

## What should happen next

1. **Run the experiment for an additional 2–3 weeks** (to day 35–42) to determine whether the effect stabilizes, continues to decay, or reverses toward baseline.
2. **Alternatively, segment analysis**: If you can't extend the test, analyze whether the Week 1 novelty effect differs by cohort (e.g., new users vs. returning users). New users may show persistent effects even if the overall population shows decay.
3. **Only proceed to rollout if**:
   - Extended observation shows stabilization above ≥1.5–2pp, OR
   - Segment analysis reveals a meaningful sustained subgroup effect worth targeting.

## Trade-offs

- **Delaying vs. Q3 deadline**: Missing the "count toward Q3" window is a legitimate cost, but shipping a novelty effect that decays week-to-week will also disappoint in post-launch monitoring. Better to extend the test than to disguise a transient effect as a lasting win.
- **Business pressure**: The team's desire to ship by end-of-week is understandable, but it conflicts with the evidence. The decay pattern is red flagging that more observation is needed.

## Missing business inputs that weaken this recommendation

- How much longer can the test run? (If you have only 3 days, the calculus changes.)
- Does the product roadmap depend critically on "shipping something toward the Q3 OKR this week," or is there flexibility to defer to achieve a more robust result?
- Is there segment-level analysis available (new vs. returning users, engagement cohorts, regions) that would clarify whether the effect is durable for subgroups?

## Summary

This experiment has good execution quality, clean guardrails, and a statistically significant headline result. However, the evidence strongly points to a novelty effect rather than a sustained product improvement. Rolling out based on the aggregate p-value and deadline pressure would conflate statistical significance with practical durability—and the week-by-week trend directly contradicts that assumption. Extend the test or segment the analysis to clarify whether this effect stabilizes. Do not ship this week.
